{"protocolSection":{"identificationModule":{"nctId":"NCT00257608","orgStudyIdInfo":{"id":"AVF3671g"},"secondaryIdInfos":[{"id":"BO20800","type":"OTHER","domain":"Hoffmann-La Roche"}],"organization":{"fullName":"Genentech, Inc.","class":"INDUSTRY"},"briefTitle":"A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab Therapy With or Without Erlotinib After Completion of Chemotherapy With Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer"},"statusModule":{"statusVerifiedDate":"2016-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2006-01"},"primaryCompletionDateStruct":{"date":"2014-11","type":"ACTUAL"},"completionDateStruct":{"date":"2014-11","type":"ACTUAL"},"studyFirstSubmitDate":"2005-11-21","studyFirstSubmitQcDate":"2005-11-21","studyFirstPostDateStruct":{"date":"2005-11-23","type":"ESTIMATED"},"resultsFirstSubmitDate":"2015-11-09","resultsFirstSubmitQcDate":"2016-02-16","resultsFirstPostDateStruct":{"date":"2016-03-15","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-03-18","lastUpdatePostDateStruct":{"date":"2016-04-18","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Genentech, Inc.","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"This is a Phase IIIb, multicenter, randomized, placebo-controlled trial to evaluate the safety and efficacy of chemotherapy+bevacizumab followed by bevacizumab+erlotinib versus bevacizumab+erlotinib placebo in subjects with locally advanced or metastatic NSCLC."},"conditionsModule":{"conditions":["Non-Small Cell Lung Cancer"],"keywords":["NSCLC","Lung Cancer","ATLAS","Avastin","Tarceva"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":1145,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: bevacizumab","Drug: erlotinib HCl"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: bevacizumab","Drug: placebo"]}],"interventions":[{"type":"DRUG","name":"bevacizumab","description":"Intravenous repeating dose","armGroupLabels":["1","2"]},{"type":"DRUG","name":"placebo","description":"Oral repeating dose","armGroupLabels":["2"]},{"type":"DRUG","name":"erlotinib HCl","description":"Oral repeating dose","armGroupLabels":["1"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Progression-free Survival (PFS)","description":"PFS was defined as the length of time from randomization until documented disease progression or death from any cause, whichever occurred earlier. Progression is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions. Data presented until cut-off date 18 July 2008.","timeFrame":"Approximately 3 years"}],"secondaryOutcomes":[{"measure":"Number of Participants With Prospectively Identified Treatment Emergent Adverse Events (TEAE) During Chemotherapy Phase","description":"Treatment-emergent adverse events were events between administration of study drug and up to 30 days after last dose of study drug that were absent before treatment or that worsened relative to pre-treatment state.. Number of participants who had Grade \\>=3TEAEs of pulmonary hemorrhage, gastrointestinal (GI) perforation, arterial thromboembolic (ATE) events, proteinuria, congestive heart failure (CHF), and hypertension were presented. Data presented up to data cutoff 18 July 2008.","timeFrame":"Approximately 3 years"},{"measure":"Number of Participants With Prospectively Identified Treatment Emergent Adverse Events (TEAE) During Post-Chemotherapy Phase","description":"Treatment-related adverse events are defined as new events that occur following subject entry into the study or events that worsen following study entry state and are judged by the investigator to be possibly, probably or definitely related to study medication. Pulmonary hemorrhage, GI perforation, ATE events, proteinuria, CHF, and hypertension were prospectively identified TEAEs of grade \\>=3. Data presented until cut-off date 28 January 2009.","timeFrame":"Approximately 3 years"},{"measure":"Number of Participants With Any Adverse Events During Post-Chemotherapy Phase","description":"An AE is defined as any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An SAE is defined as any untoward medical occurrence that, at any dose, results in death, is life threatening, requires hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or is a significant medical event. Data presented up to data cutoff 19 June 2009.","timeFrame":"Approximately 3.5 years"},{"measure":"Incidence of Study Treatment Discontinuation for Reasons Other Than Disease Progression in Chemotherapy Phase","description":"Participants who experienced disease progression were discontinued from the study. Data presented up to data cutoff (18 July 2008).","timeFrame":"Approximately 3 years"},{"measure":"Incidence of Study Treatment Discontinuation","description":"Participants in post-chemotherapy phase were discontinued from the study for the reasons other than disease progression. Data presented Up to data cutoff 18 July 2008.","timeFrame":"Approximately 3 years"},{"measure":"Overall Survival","description":"Overall survival was defined as the length of time from randomization to death.","timeFrame":"Approximately 3.5 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Signed Informed Consent Form\n* Histologically or cytologically confirmed NSCLC\n* Advanced NSCLC or recurrent disease\n* INR no greater than 1.3 and aPTT no greater than upper limits of normal (ULN) within 28 days prior to enrollment for subjects not on low molecular weight heparin or fondaparinux. Subjects on low molecular weight heparin or fondaparinux are not required to meet INR or aPTT limits. Chronic full-dose anticoagulation with warfarin is not permitted.\n* 18 years of age or older\n* For women of childbearing potential and sexually active men, use of an accepted and effective method of contraception (hormonal or barrier methods, abstinence) prior to enrollment and for the duration of the study\n\nExclusion Criteria:\n\n* Prior systemic chemotherapy in the metastatic setting\n* Treatment with an investigational or marketed agent that acts by either EGFR inhibition or anti-angiogenesis mechanisms\n* Pregnancy or lactation\n* Any other medical condition, including mental illness or substance abuse, deemed by the clinician to be likely to interfere with a subject's ability to provide informed consent, cooperate, and participate in the study, or to interfere with the interpretation of the results\n* Active infection or a fever within 3 days of enrollment\n* Active malignancy other than lung cancer\n* Radiation therapy to sites other than whole brain within 14 days prior to enrollment\n* History of gross hemoptysis within 3 months prior to enrollment\n* Known hypersensitivity to any of the components of cytotoxic chemotherapy combinations, bevacizumab, or tyrosine kinase inhibitors\n* Inadequately controlled hypertension\n* Unstable angina or New York Heart Association Grade II or greater CHF\n* Abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within 6 months prior to enrollment\n* History of myocardial infarction within 6 months prior to enrollment\n* History of stroke within 6 months prior to enrollment\n* Symptomatic peripheral vascular disease within 6 months prior to enrollment\n* Evidence of bleeding diathesis or coagulopathy\n* Serious, non-healing wound, ulcer, or bone fracture\n* Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to enrollment; anticipation of need for major surgical procedure during the course of the study\n* Current, recent, or planned participation in an experimental drug study other than this Genentech-sponsored bevacizumab/erlotinib study\n* Progressive neurologic symptoms in subjects with a history of brain metastases\n* History of significant vascular disease (e.g., aortic aneurysm)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Donald Strickland, M.D.","affiliation":"Genentech, Inc.","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Sacred Heart Medical Onc Group","city":"Mobile","state":"Alabama","zip":"36608","country":"United States","geoPoint":{"lat":30.69436,"lon":-88.04305}},{"facility":"St. Edward Mercy Medical Ctr","city":"Fort Smith","state":"Arizona","zip":"72917","country":"United States"},{"facility":"Mayo Clinic","city":"Scottsdale","state":"Arizona","zip":"85259","country":"United States","geoPoint":{"lat":33.50921,"lon":-111.89903}},{"facility":"Arizona Cancer Center","city":"Tucson","state":"Arizona","zip":"85724","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Central Hem/Onc Medical Group","city":"Alhambra","state":"California","zip":"91801","country":"United States","geoPoint":{"lat":34.09529,"lon":-118.12701}},{"facility":"Comp Blood & Cancer Center","city":"Bakersfield","state":"California","zip":"93309","country":"United States","geoPoint":{"lat":35.37329,"lon":-119.01871}},{"facility":"South Bay Oncology","city":"Campbell","state":"California","zip":"95008","country":"United States","geoPoint":{"lat":37.28717,"lon":-121.94996}},{"facility":"Bay Area Cancer Research Grp","city":"Concord","state":"California","zip":"94598","country":"United States","geoPoint":{"lat":37.97798,"lon":-122.03107}},{"facility":"Pacific Onc & Hem Assoc","city":"Encinitas","state":"California","zip":"92024","country":"United States","geoPoint":{"lat":33.03699,"lon":-117.29198}},{"facility":"Pacific Coast Hem/Onc","city":"Fountain Valley","state":"California","zip":"92708","country":"United States","geoPoint":{"lat":33.70918,"lon":-117.95367}},{"facility":"Cancer Care Associates","city":"Fresno","state":"California","zip":"93720","country":"United States","geoPoint":{"lat":36.74773,"lon":-119.77237}},{"facility":"St. Jude Heritage Med Group","city":"Fullerton","state":"California","zip":"92835","country":"United States","geoPoint":{"lat":33.87029,"lon":-117.92534}},{"facility":"Ronald H. Yanagihara","city":"Gilroy","state":"California","zip":"95020","country":"United States","geoPoint":{"lat":37.00578,"lon":-121.56828}},{"facility":"Glendale Adventist Medical Ctr","city":"Glendale","state":"California","zip":"91206","country":"United States","geoPoint":{"lat":34.14251,"lon":-118.25508}},{"facility":"Scipps Clinic","city":"La Jolla","state":"California","zip":"92037-1027","country":"United States","geoPoint":{"lat":32.84727,"lon":-117.2742}},{"facility":"Loma Linda Univ Medical Center","city":"Loma Linda","state":"California","zip":"92354","country":"United States","geoPoint":{"lat":34.04835,"lon":-117.26115}},{"facility":"Pacific Shores Medical Group","city":"Long Beach","state":"California","zip":"90813","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"Kenmar Research Institute LLC","city":"Los Angeles","state":"California","zip":"90057","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"UCLA Medical Ctr","city":"Los Angeles","state":"California","zip":"90095","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"Sutter Gould Med Foundation","city":"Modesto","state":"California","zip":"95355","country":"United States","geoPoint":{"lat":37.6391,"lon":-120.99688}},{"facility":"North Valley Hem Onc Med Grp","city":"Northridge","state":"California","zip":"91325","country":"United States","geoPoint":{"lat":34.22834,"lon":-118.53675}},{"facility":"Hem Onc Med Grp Orange Cty","city":"Orange","state":"California","zip":"92868","country":"United States","geoPoint":{"lat":33.78779,"lon":-117.85311}},{"facility":"Medical Oncology Care Assoc","city":"Orange","state":"California","zip":"92868","country":"United States","geoPoint":{"lat":33.78779,"lon":-117.85311}},{"facility":"Ventura Co Hem-Onc Specialists","city":"Oxnard","state":"California","zip":"93030","country":"United States","geoPoint":{"lat":34.1975,"lon":-119.17705}},{"facility":"Wilshire Oncology Medical Grp","city":"Pomona","state":"California","zip":"91767","country":"United States","geoPoint":{"lat":34.05529,"lon":-117.75228}},{"facility":"Sutter Cancer Center","city":"Sacramento","state":"California","zip":"95816","country":"United States","geoPoint":{"lat":38.58157,"lon":-121.4944}},{"facility":"Mercy General Hospital","city":"Sacramento","state":"California","zip":"95819","country":"United States","geoPoint":{"lat":38.58157,"lon":-121.4944}},{"facility":"Los Palos Oncology & Hem","city":"Salinas","state":"California","zip":"93901","country":"United States","geoPoint":{"lat":36.67774,"lon":-121.6555}},{"facility":"Kaiser Permanente","city":"San Diego","state":"California","zip":"92120","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"Naval Medical Center","city":"San Diego","state":"California","zip":"92134","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"Pacific Hematology Oncology","city":"San Francisco","state":"California","zip":"94115","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"Kaiser Permanente Santa Teresa","city":"San Jose","state":"California","zip":"95119","country":"United States","geoPoint":{"lat":37.33939,"lon":-121.89496}},{"facility":"Sansum Medical Clinic, Inc.","city":"Santa Barbara","state":"California","zip":"93105","country":"United States","geoPoint":{"lat":34.42083,"lon":-119.69819}},{"facility":"Santa Barbara Hem Onc Med Grp","city":"Santa Barbara","state":"California","zip":"93105","country":"United States","geoPoint":{"lat":34.42083,"lon":-119.69819}},{"facility":"Central Coast Medical Oncology","city":"Santa Maria","state":"California","zip":"93454","country":"United States","geoPoint":{"lat":34.95303,"lon":-120.43572}},{"facility":"The Angeles Clinic","city":"Santa Monica","state":"California","zip":"90404","country":"United States","geoPoint":{"lat":34.01949,"lon":-118.49138}},{"facility":"Redwood Regional Med Grp","city":"Santa Rosa","state":"California","zip":"95403","country":"United States","geoPoint":{"lat":38.44047,"lon":-122.71443}},{"facility":"Cancer Care Associates","city":"Torrance","state":"California","zip":"90505","country":"United States","geoPoint":{"lat":33.83585,"lon":-118.34063}},{"facility":"Mile High Oncology","city":"Denver","state":"Colorado","zip":"80210","country":"United States","geoPoint":{"lat":39.73915,"lon":-104.9847}},{"facility":"Front Range Cancer Specialists","city":"Fort Collins","state":"Colorado","zip":"80524","country":"United States","geoPoint":{"lat":40.58526,"lon":-105.08442}},{"facility":"Washington Onc Hem Center PC","city":"Washington D.C.","state":"District of Columbia","zip":"20037","country":"United States","geoPoint":{"lat":38.89511,"lon":-77.03637}},{"facility":"Center for Hematology-Oncology","city":"Boca Raton","state":"Florida","zip":"33486","country":"United States","geoPoint":{"lat":26.35869,"lon":-80.0831}},{"facility":"Halifax Medical Center","city":"Daytona Beach","state":"Florida","zip":"32115","country":"United States","geoPoint":{"lat":29.21081,"lon":-81.02283}},{"facility":"Florida Wellcare Alliance","city":"Inverness","state":"Florida","zip":"34452","country":"United States","geoPoint":{"lat":28.83582,"lon":-82.33037}},{"facility":"Baptist Cancer Institute","city":"Jacksonville","state":"Florida","zip":"32207","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"Jackson Memorial Hospital","city":"Miami","state":"Florida","zip":"33136","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Mid-Florida Hem Oncology Ctr","city":"Orange City","state":"Florida","zip":"32763","country":"United States","geoPoint":{"lat":28.94888,"lon":-81.29867}},{"facility":"Integrated Comm Onc Network","city":"Orange Park","state":"Florida","zip":"32073","country":"United States","geoPoint":{"lat":30.16607,"lon":-81.70648}},{"facility":"Hematology Onc Treasure Coast","city":"Port Saint Lucie","state":"Florida","zip":"34952","country":"United States","geoPoint":{"lat":27.29393,"lon":-80.35033}},{"facility":"Phoebe Putney Cancer Center","city":"Albany","state":"Georgia","zip":"31701","country":"United States","geoPoint":{"lat":31.57851,"lon":-84.15574}},{"facility":"Northeast Georgia Cancer Care","city":"Athens","state":"Georgia","zip":"30607","country":"United States","geoPoint":{"lat":33.96095,"lon":-83.37794}},{"facility":"Suburban Hem-Onc Associates","city":"Lawrenceville","state":"Georgia","zip":"30045","country":"United States","geoPoint":{"lat":33.95621,"lon":-83.98796}},{"facility":"Northwest Georgia Onc Centers","city":"Marietta","state":"Georgia","zip":"30060","country":"United States","geoPoint":{"lat":33.9526,"lon":-84.54993}},{"facility":"Chicagoland Hematology Onc","city":"Arlington Heights","state":"Illinois","zip":"60005","country":"United States","geoPoint":{"lat":42.08836,"lon":-87.98063}},{"facility":"Weiss-Strauss Oncology Center","city":"Chicago","state":"Illinois","zip":"60640","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"LaGrange Oncology Associates","city":"Geneva","state":"Illinois","zip":"54301","country":"United States","geoPoint":{"lat":41.88753,"lon":-88.30535}},{"facility":"La Grange Oncology Associates","city":"LaGrange","state":"Illinois","zip":"60525","country":"United States","geoPoint":{"lat":41.80568,"lon":-87.86942}},{"facility":"Associates in Medical Oncology","city":"Oak Lawn","state":"Illinois","zip":"60453","country":"United States","geoPoint":{"lat":41.71087,"lon":-87.75811}},{"facility":"Onc Hem Assoc of Central IL","city":"Peoria","state":"Illinois","zip":"61615","country":"United States","geoPoint":{"lat":40.69365,"lon":-89.58899}},{"facility":"West Suburban Cancer Center","city":"River Forest","state":"Illinois","zip":"60305","country":"United States","geoPoint":{"lat":41.89781,"lon":-87.81395}},{"facility":"OSF St. Anthony Med Ctr","city":"Rockford","state":"Illinois","zip":"61108","country":"United States","geoPoint":{"lat":42.27113,"lon":-89.094}},{"facility":"Community Hospital","city":"Munster","state":"Indiana","zip":"46321","country":"United States","geoPoint":{"lat":41.56448,"lon":-87.51254}},{"facility":"Providence Medical Group","city":"Terre Haute","state":"Indiana","zip":"47802","country":"United States","geoPoint":{"lat":39.4667,"lon":-87.41391}},{"facility":"Hematology Oncology Associates","city":"Bettendorf","state":"Iowa","zip":"52722","country":"United States","geoPoint":{"lat":41.52448,"lon":-90.51569}},{"facility":"Siouxland Hem-Onc Assoc LLP","city":"Sioux City","state":"Iowa","zip":"51101","country":"United States","geoPoint":{"lat":42.49999,"lon":-96.40031}},{"facility":"Covenant Clinic","city":"Waterloo","state":"Iowa","zip":"50702","country":"United States","geoPoint":{"lat":42.49276,"lon":-92.34296}},{"facility":"Gajera & Patel, PLLC","city":"Hopkinsville","state":"Kentucky","zip":"42240","country":"United States","geoPoint":{"lat":36.86561,"lon":-87.49117}},{"facility":"Kentuckiana Cancer Center","city":"Louisville","state":"Kentucky","zip":"40202","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}},{"facility":"University of Louisville","city":"Louisville","state":"Kentucky","zip":"40202","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}},{"facility":"Consultants in Blood Disorders","city":"Louisville","state":"Kentucky","zip":"40207","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}},{"facility":"Owensboro Medical Health Sys","city":"Owensboro","state":"Kentucky","zip":"42303","country":"United States","geoPoint":{"lat":37.77422,"lon":-87.11333}},{"facility":"Willis-Knighton Cancer Center","city":"Shreveport","state":"Louisiana","zip":"71103","country":"United States","geoPoint":{"lat":32.52515,"lon":-93.75018}},{"facility":"H&J Weinberg Cancer Institute","city":"Baltimore","state":"Maryland","zip":"21237","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"Oncology Hematology Associates","city":"Clinton","state":"Maryland","zip":"20735","country":"United States","geoPoint":{"lat":38.76511,"lon":-76.89831}},{"facility":"Maryland Oncology/Hema PA","city":"Columbia","state":"Maryland","zip":"21044","country":"United States","geoPoint":{"lat":39.24038,"lon":-76.83942}},{"facility":"Frederick Memorial Hospital","city":"Frederick","state":"Maryland","zip":"21701","country":"United States","geoPoint":{"lat":39.41427,"lon":-77.41054}},{"facility":"Dana Farber Cancer Institute","city":"Boston","state":"Massachusetts","zip":"02115","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"Caritas St. Elizabeth Med Ctr","city":"Boston","state":"Massachusetts","zip":"02135","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"Lahey Clinic Med Ctr","city":"Burlington","state":"Massachusetts","zip":"01805","country":"United States","geoPoint":{"lat":42.50482,"lon":-71.19561}},{"facility":"Metrowest Cancer Center","city":"Framingham","state":"Massachusetts","zip":"01702","country":"United States","geoPoint":{"lat":42.27926,"lon":-71.41617}},{"facility":"Baystate Medical Center","city":"Springfield","state":"Massachusetts","zip":"01107","country":"United States","geoPoint":{"lat":42.10148,"lon":-72.58981}},{"facility":"Spectrum Health","city":"Grand Rapids","state":"Michigan","zip":"49503","country":"United States","geoPoint":{"lat":42.96336,"lon":-85.66809}},{"facility":"Kalamazoo Hem & Onc","city":"Kalamazoo","state":"Michigan","zip":"49048","country":"United States","geoPoint":{"lat":42.29171,"lon":-85.58723}},{"facility":"Marquette General Health Sys","city":"Marquette","state":"Michigan","zip":"49855","country":"United States","geoPoint":{"lat":46.54354,"lon":-87.39542}},{"facility":"St. Joseph Mercy Oakland","city":"Pontiac","state":"Michigan","zip":"48341","country":"United States","geoPoint":{"lat":42.63892,"lon":-83.29105}},{"facility":"William Beaumont Hospital","city":"Royal Oak","state":"Michigan","zip":"48073","country":"United States","geoPoint":{"lat":42.48948,"lon":-83.14465}},{"facility":"Virginia Piper Cancer Inst","city":"Minneapolis","state":"Minnesota","zip":"55407","country":"United States","geoPoint":{"lat":44.97997,"lon":-93.26384}},{"facility":"Ellis Fischel Cancer Center","city":"Columbia","state":"Missouri","zip":"65203","country":"United States","geoPoint":{"lat":38.95171,"lon":-92.33407}},{"facility":"Freeman Cancer Institute","city":"Joplin","state":"Missouri","zip":"64804","country":"United States","geoPoint":{"lat":37.08423,"lon":-94.51328}},{"facility":"Missouri Cancer Center, PC","city":"Saint Charles","state":"Missouri","zip":"63301","country":"United States","geoPoint":{"lat":38.78394,"lon":-90.48123}},{"facility":"St. Louis Univ Care Center","city":"St Louis","state":"Missouri","zip":"63117","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"Arch Medical Services","city":"Washington","state":"Missouri","zip":"63090","country":"United States","geoPoint":{"lat":38.55811,"lon":-91.01209}},{"facility":"Billings Clinic","city":"Billings","state":"Montana","zip":"59101","country":"United States","geoPoint":{"lat":45.78329,"lon":-108.50069}},{"facility":"Big Sky Oncology","city":"Great Falls","state":"Montana","zip":"59405","country":"United States","geoPoint":{"lat":47.50024,"lon":-111.30081}},{"facility":"Montana Cancer Specialists","city":"Missoula","state":"Montana","zip":"59802","country":"United States","geoPoint":{"lat":46.87215,"lon":-113.994}},{"facility":"NE Hematology Oncology, PC","city":"Lincoln","state":"Nebraska","zip":"68506","country":"United States","geoPoint":{"lat":40.8,"lon":-96.66696}},{"facility":"Nebraska Methodist Hospital","city":"Omaha","state":"Nebraska","zip":"68114","country":"United States","geoPoint":{"lat":41.25626,"lon":-95.94043}},{"facility":"Comp Cancer Centers of Nevada","city":"Las Vegas","state":"Nevada","zip":"89109","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"Ctr for Cancer & Hem Disease","city":"Cherry Hill","state":"New Jersey","zip":"08003","country":"United States","geoPoint":{"lat":39.93484,"lon":-75.03073}},{"facility":"Forte, Attas & Schleider","city":"Englewood","state":"New Jersey","zip":"07631","country":"United States","geoPoint":{"lat":40.89288,"lon":-73.97264}},{"facility":"Hunterdon Medical Center","city":"Flemington","state":"New Jersey","zip":"08822","country":"United States","geoPoint":{"lat":40.51233,"lon":-74.85933}},{"facility":"Central State Medical Center","city":"Freehold","state":"New Jersey","zip":"07728","country":"United States","geoPoint":{"lat":40.26011,"lon":-74.27376}},{"facility":"St. Barnabas Health Care Sys","city":"Livingston","state":"New Jersey","zip":"07039","country":"United States","geoPoint":{"lat":40.79593,"lon":-74.31487}},{"facility":"Mountainside Hospital","city":"Montclair","state":"New Jersey","zip":"07042","country":"United States","geoPoint":{"lat":40.82593,"lon":-74.20903}},{"facility":"Morristown Memorial Hospital","city":"Morristown","state":"New Jersey","zip":"07962","country":"United States","geoPoint":{"lat":40.79677,"lon":-74.48154}},{"facility":"Hematology Oncology Assoc SJ","city":"Mount Holly","state":"New Jersey","zip":"08060","country":"United States","geoPoint":{"lat":39.99289,"lon":-74.78766}},{"facility":"Jersey Shore Medical Center","city":"Neptune City","state":"New Jersey","zip":"07754","country":"United States","geoPoint":{"lat":40.20011,"lon":-74.02792}},{"facility":"Cancer Institute of New Jersey","city":"New Brunswick","state":"New Jersey","zip":"08901","country":"United States","geoPoint":{"lat":40.48622,"lon":-74.45182}},{"facility":"The Valley Hospital","city":"Paramus","state":"New Jersey","zip":"07652","country":"United States","geoPoint":{"lat":40.94454,"lon":-74.07542}},{"facility":"Overlook Hospital","city":"Summit","state":"New Jersey","zip":"07902","country":"United States","geoPoint":{"lat":40.71562,"lon":-74.36468}},{"facility":"Holy Name Hospital","city":"Teaneck","state":"New Jersey","zip":"07666","country":"United States","geoPoint":{"lat":40.8976,"lon":-74.01597}},{"facility":"San Juan Onco Assoc","city":"Farmington","state":"New Mexico","zip":"87401","country":"United States","geoPoint":{"lat":36.72806,"lon":-108.21869}},{"facility":"Zale P Bernstein MD - PP","city":"Buffalo","state":"New York","zip":"14215","country":"United States","geoPoint":{"lat":42.88645,"lon":-78.87837}},{"facility":"Bassett Cancer Center","city":"Cooperstown","state":"New York","zip":"13326","country":"United States","geoPoint":{"lat":42.70048,"lon":-74.92426}},{"facility":"Adriondack Cancer Care","city":"Glen Falls","state":"New York","zip":"12801","country":"United States"},{"facility":"BRANY","city":"Great Neck","state":"New York","zip":"11021","country":"United States","geoPoint":{"lat":40.80066,"lon":-73.72846}},{"facility":"Queens Cancer Center","city":"Jamaica","state":"New York","zip":"11432","country":"United States","geoPoint":{"lat":40.69149,"lon":-73.80569}},{"facility":"Crystal Run Health Care","city":"Middletown","state":"New York","zip":"10941","country":"United States","geoPoint":{"lat":41.44593,"lon":-74.42293}},{"facility":"NYU Medical Center","city":"New York","state":"New York","zip":"10016","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Mem Sloan Kettering Cancer Ctr","city":"New York","state":"New York","zip":"10021","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"SUNY Upstate","city":"Syracuse","state":"New York","zip":"13210","country":"United States","geoPoint":{"lat":43.04812,"lon":-76.14742}},{"facility":"Presbyterian Hospital","city":"Charlotte","state":"North Carolina","zip":"28204","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"NorthEast Medical Center","city":"Concord","state":"North Carolina","zip":"28025","country":"United States","geoPoint":{"lat":35.40888,"lon":-80.58158}},{"facility":"Moses Cone Reg Cncr Ctr","city":"Greensboro","state":"North Carolina","zip":"27403","country":"United States","geoPoint":{"lat":36.07264,"lon":-79.79198}},{"facility":"Emerywood Hematology Oncology","city":"High Point","state":"North Carolina","zip":"27262","country":"United States","geoPoint":{"lat":35.95569,"lon":-80.00532}},{"facility":"Carolina BioOncology Institute","city":"Huntersville","state":"North Carolina","zip":"28078","country":"United States","geoPoint":{"lat":35.41069,"lon":-80.84285}},{"facility":"Kinston Medical Specialists","city":"Kinston","state":"North Carolina","zip":"28501","country":"United States","geoPoint":{"lat":35.26266,"lon":-77.58164}},{"facility":"Beaufort County Hospital","city":"Washington","state":"North Carolina","zip":"27889","country":"United States","geoPoint":{"lat":35.54655,"lon":-77.05217}},{"facility":"Summa Health System","city":"Akron","state":"Ohio","zip":"44304","country":"United States","geoPoint":{"lat":41.08144,"lon":-81.51901}},{"facility":"Akron General Medical Center","city":"Akron","state":"Ohio","zip":"44307","country":"United States","geoPoint":{"lat":41.08144,"lon":-81.51901}},{"facility":"Aultman Hospital","city":"Canton","state":"Ohio","zip":"44710","country":"United States","geoPoint":{"lat":40.79895,"lon":-81.37845}},{"facility":"Gabrail Cancer Center","city":"Canton","state":"Ohio","zip":"44718","country":"United States","geoPoint":{"lat":40.79895,"lon":-81.37845}},{"facility":"Onc/Hem Care Clin Trials LLC","city":"Cincinnati","state":"Ohio","zip":"45242","country":"United States","geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"MetroHealth Medical Center","city":"Cleveland","state":"Ohio","zip":"44109","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"Mid Ohio Onc Hematology Inc","city":"Columbus","state":"Ohio","zip":"43213","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"Riverside Methodist Hospital","city":"Columbus","state":"Ohio","zip":"43214","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"Dayton Clinical Oncology Prog","city":"Dayton","state":"Ohio","zip":"45429","country":"United States","geoPoint":{"lat":39.75895,"lon":-84.19161}},{"facility":"Ohio Cancer Specialists","city":"Mansfield","state":"Ohio","zip":"44907","country":"United States","geoPoint":{"lat":40.75839,"lon":-82.51545}},{"facility":"Signal Point Hem/Oncology Inc","city":"Middletown","state":"Ohio","zip":"45042","country":"United States","geoPoint":{"lat":39.51506,"lon":-84.39828}},{"facility":"Toledo Community Hospital","city":"Toledo","state":"Ohio","zip":"43623","country":"United States","geoPoint":{"lat":41.66394,"lon":-83.55521}},{"facility":"Forum Health Cancer Care Ctr","city":"Youngstown","state":"Ohio","zip":"44501","country":"United States","geoPoint":{"lat":41.09978,"lon":-80.64952}},{"facility":"Providence Portland Med Center","city":"Portland","state":"Oregon","zip":"97213","country":"United States","geoPoint":{"lat":45.52345,"lon":-122.67621}},{"facility":"Ephrata Cancer Center","city":"Ephrata","state":"Pennsylvania","zip":"17543","country":"United States","geoPoint":{"lat":40.17982,"lon":-76.17884}},{"facility":"Armstrong County Memorial Hosp","city":"Kittanning","state":"Pennsylvania","zip":"16201","country":"United States","geoPoint":{"lat":40.81645,"lon":-79.52199}},{"facility":"Hem Onc Assoc Phys Lancaster","city":"Lancaster","state":"Pennsylvania","zip":"17604","country":"United States","geoPoint":{"lat":40.03788,"lon":-76.30551}},{"facility":"University of Pennsylvania","city":"Philadelphia","state":"Pennsylvania","zip":"19104","country":"United States","geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"Scranton Hematology Oncology","city":"Scranton","state":"Pennsylvania","zip":"18510","country":"United States","geoPoint":{"lat":41.40916,"lon":-75.6649}},{"facility":"Assoc in Hematology Oncology","city":"Upland","state":"Pennsylvania","zip":"19013","country":"United States","geoPoint":{"lat":39.85261,"lon":-75.38269}},{"facility":"Lankenau Medical Office Bldg","city":"Wynnewood","state":"Pennsylvania","zip":"19096","country":"United States","geoPoint":{"lat":40.00289,"lon":-75.27074}},{"facility":"Charleston Cancer Center","city":"Charleston","state":"South Carolina","zip":"29406","country":"United States","geoPoint":{"lat":32.77632,"lon":-79.93275}},{"facility":"Palmetto Hematology Oncology","city":"Spartanburg","state":"South Carolina","zip":"29303","country":"United States","geoPoint":{"lat":34.94957,"lon":-81.93205}},{"facility":"Erlanger Health Systems","city":"Chattanooga","state":"Tennessee","zip":"37403","country":"United States","geoPoint":{"lat":35.04563,"lon":-85.30968}},{"facility":"The Jones Clinic","city":"Germantown","state":"Tennessee","zip":"38138","country":"United States","geoPoint":{"lat":35.08676,"lon":-89.81009}},{"facility":"Jackson-Madsion County Hosp","city":"Jackson","state":"Tennessee","zip":"38301","country":"United States","geoPoint":{"lat":35.61452,"lon":-88.81395}},{"facility":"Clopton Clinic","city":"Memphis","state":"Tennessee","zip":"38138","country":"United States","geoPoint":{"lat":35.14953,"lon":-90.04898}},{"facility":"Sarah Cannon Cancer Center","city":"Nashville","state":"Tennessee","zip":"37203-1632","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Vanderbilt University Medical","city":"Nashville","state":"Tennessee","zip":"37232","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Lone Star Oncology Consultants","city":"Austin","state":"Texas","zip":"78759","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"Coastal Bend Cancer Center","city":"Corpus Christi","state":"Texas","zip":"78404","country":"United States","geoPoint":{"lat":27.80058,"lon":-97.39638}},{"facility":"Texas Cancer Associates","city":"Dallas","state":"Texas","zip":"75231","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Texas Hematology Oncology","city":"Dallas","state":"Texas","zip":"75234","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"JPS Center for Cancer Care","city":"Fort Worth","state":"Texas","zip":"76104","country":"United States","geoPoint":{"lat":32.72541,"lon":-97.32085}},{"facility":"Univ of Texas Medical Branch","city":"Galveston","state":"Texas","zip":"77555","country":"United States","geoPoint":{"lat":29.30135,"lon":-94.7977}},{"facility":"Wilford Hall Medical Center","city":"Lackland Air Force Base","state":"Texas","zip":"78236","country":"United States","geoPoint":{"lat":29.38663,"lon":-98.61797}},{"facility":"SW Vermont Healthcare Onc Asoc","city":"Bennington","state":"Vermont","zip":"05201","country":"United States","geoPoint":{"lat":42.87813,"lon":-73.19677}},{"facility":"Vermont Ctr Cancer Medicine","city":"Colchester","state":"Vermont","zip":"05446","country":"United States","geoPoint":{"lat":44.54394,"lon":-73.14791}},{"facility":"Community Cancer Center","city":"Rutland","state":"Vermont","zip":"05701","country":"United States","geoPoint":{"lat":43.61062,"lon":-72.97261}},{"facility":"Peninsula Cancer Institute","city":"Newport News","state":"Virginia","zip":"23606","country":"United States","geoPoint":{"lat":36.98038,"lon":-76.42975}},{"facility":"SW Virginia Hem Onc","city":"Roanoke","state":"Virginia","zip":"24014","country":"United States","geoPoint":{"lat":37.27097,"lon":-79.94143}},{"facility":"Cascade Cancer Center","city":"Kirkland","state":"Washington","zip":"98034","country":"United States","geoPoint":{"lat":47.68149,"lon":-122.20874}},{"facility":"Northwest Medical Specialists","city":"Tacoma","state":"Washington","zip":"98405","country":"United States","geoPoint":{"lat":47.25288,"lon":-122.44429}},{"facility":"Univ Physicians Internal Med","city":"Huntington","state":"West Virginia","zip":"25701","country":"United States","geoPoint":{"lat":38.41925,"lon":-82.44515}},{"facility":"West Virginia University","city":"Morgantown","state":"West Virginia","zip":"26506","country":"United States","geoPoint":{"lat":39.62953,"lon":-79.9559}},{"facility":"Oncology Alliance","city":"Glendale","state":"Wisconsin","zip":"53212","country":"United States","geoPoint":{"lat":43.13529,"lon":-87.93564}},{"facility":"Dean Clinic","city":"Madison","state":"Wisconsin","zip":"53715","country":"United States","geoPoint":{"lat":43.07305,"lon":-89.40123}},{"facility":"Medical Consultants LTD","city":"Milwaukee","state":"Wisconsin","zip":"53215","country":"United States","geoPoint":{"lat":43.0389,"lon":-87.90647}},{"facility":"All Saints Cancer Center","city":"Racine","state":"Wisconsin","zip":"53405","country":"United States","geoPoint":{"lat":42.72613,"lon":-87.78285}},{"facility":"Hospital Pirovano","city":"Buenos Aires","zip":"1430","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"Hospital Britanico","city":"Buenos Aires","zip":"C1284AEB","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"Hospital Toru","city":"Buenos Aires","zip":"C1427ARN","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"CEMIC","city":"Buenos Aires","zip":"C1431FWO","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"Centro Oncologico de Cordoba","city":"Córdoba","zip":"X5000AAI","country":"Argentina","geoPoint":{"lat":-31.40648,"lon":-64.18853}},{"facility":"COIR","city":"Mendoza","zip":"5500","country":"Argentina","geoPoint":{"lat":-32.88946,"lon":-68.84582}},{"facility":"Instituto Medico Privado","city":"Resistencia","zip":"3900","country":"Argentina","geoPoint":{"lat":-27.46363,"lon":-58.98665}},{"facility":"Clinica Oncologica de Rosario","city":"Rosario","zip":"S2000dsk","country":"Argentina","geoPoint":{"lat":-32.94682,"lon":-60.63932}},{"facility":"ISIS Clinica Especializada","city":"Sante Fe","zip":"S3000FFU","country":"Argentina"},{"facility":"Holy Spirit Hospital Northside","city":"Chermside, QLD","zip":"4032","country":"Australia","geoPoint":{"lat":-27.38472,"lon":153.03062}},{"facility":"Sunshine Coast Cancer Centre","city":"Nambour, QLD","zip":"4560","country":"Australia","geoPoint":{"lat":-26.62613,"lon":152.95941}},{"facility":"Sir Charles Gairdner Hospital","city":"Nedlands, WA","zip":"6009","country":"Australia","geoPoint":{"lat":-31.98184,"lon":115.8073}},{"facility":"Burnside War Memorial Hospital","city":"Toorak Gardens, SA","zip":"5065","country":"Australia","geoPoint":{"lat":-34.93478,"lon":138.63639}},{"facility":"Cliniques Univ St Luc","city":"Brussels","zip":"1200","country":"Belgium","geoPoint":{"lat":50.85045,"lon":4.34878}},{"facility":"CHR Citadelle Liege","city":"Liège","zip":"4000","country":"Belgium","geoPoint":{"lat":50.63373,"lon":5.56749}},{"facility":"Instituto de cancer Arnaldo","city":"São Paulo","state":"São Paulo","zip":"01221-020","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Instituto Nacional do Cancer","city":"Rio de Janeiro","zip":"20-231-050","country":"Brazil","geoPoint":{"lat":-22.90642,"lon":-43.18223}},{"facility":"Hospital Das Clinicas","city":"São Paulo","zip":"05403-01","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Regional Oncodispensary","city":"Plovdiv","zip":"4004","country":"Bulgaria","geoPoint":{"lat":42.15387,"lon":24.75001}},{"facility":"Regional Oncodispensary","city":"Rousse","zip":"7000","country":"Bulgaria","geoPoint":{"lat":43.84872,"lon":25.9534}},{"facility":"Regional Oncodispensary","city":"Shumen","zip":"9700","country":"Bulgaria","geoPoint":{"lat":43.27064,"lon":26.92286}},{"facility":"Regional Oncodispensary","city":"Sofia","zip":"1233","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"UMHAT \"Queen Joanna\"","city":"Sofia","zip":"1527","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"National Specialized Hospital","city":"Sofia","zip":"1756","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"Regional Oncodispensary","city":"Stara Zagora","zip":"6003","country":"Bulgaria","geoPoint":{"lat":42.43205,"lon":25.64262}},{"facility":"MHAT \"St Marina\"","city":"Varna","zip":"9010","country":"Bulgaria","geoPoint":{"lat":43.21912,"lon":27.91024}},{"facility":"Regional Oncodispensary","city":"Veliko Tarnovo","zip":"5000","country":"Bulgaria","geoPoint":{"lat":43.08124,"lon":25.62904}},{"facility":"Princess Margaret Hospital","city":"Hong Kong","country":"Hong Kong","geoPoint":{"lat":22.27832,"lon":114.17469}},{"facility":"Queen Elizabeth Hospital","city":"Hong Kong","country":"Hong Kong","geoPoint":{"lat":22.27832,"lon":114.17469}},{"facility":"Queen Mary Hospital","city":"Hong Kong","country":"Hong Kong","geoPoint":{"lat":22.27832,"lon":114.17469}},{"facility":"Tuen Mun Hospital","city":"Hong Kong","country":"Hong Kong","geoPoint":{"lat":22.27832,"lon":114.17469}},{"facility":"Hadassah Medical Center","city":"Jerusalem","zip":"91120","country":"Israel","geoPoint":{"lat":31.76904,"lon":35.21633}},{"facility":"Sourasky Medical Center","city":"Tel Aviv","zip":"64239","country":"Israel","geoPoint":{"lat":32.08088,"lon":34.78057}},{"facility":"Sheba Medical Center","city":"Tel Litwinsky","zip":"52621","country":"Israel","geoPoint":{"lat":32.05096,"lon":34.84588}},{"facility":"Azienda Ospedaliera Univ","city":"Genova","zip":"16132","country":"Italy","geoPoint":{"lat":45.21604,"lon":11.87211}},{"facility":"Ist Nazion per Ricerca Cancro","city":"Genova","zip":"16132","country":"Italy","geoPoint":{"lat":45.21604,"lon":11.87211}},{"facility":"Univ degli Studi di Napoli","city":"Napoli","zip":"80131","country":"Italy","geoPoint":{"lat":40.87618,"lon":14.5195}},{"facility":"Azienda Ospedaliera","city":"Parma","zip":"43100","country":"Italy","geoPoint":{"lat":44.79935,"lon":10.32618}},{"facility":"Azienda Osper di Perugia","city":"Perugia","zip":"06159","country":"Italy","geoPoint":{"lat":43.1122,"lon":12.38878}},{"facility":"Divisione Onc Med dell'Azienda","city":"Udine","zip":"33100","country":"Italy","geoPoint":{"lat":46.0693,"lon":13.23715}},{"facility":"Torre Medica Cristobal Colon","city":"Acapulco","zip":"39670","country":"Mexico","geoPoint":{"lat":16.11417,"lon":-91.51028}},{"facility":"Inst Nacional de Cancerologia","city":"Distrito Federal","zip":"14080","country":"Mexico","geoPoint":{"lat":16.59,"lon":-93.02694}},{"facility":"ISSSTE Merida","city":"Mérida","zip":"97500","country":"Mexico","geoPoint":{"lat":20.967,"lon":-89.62318}},{"facility":"Hospital de Especialidades","city":"Torreon, Coahuila","zip":"27200","country":"Mexico"},{"facility":"Philippine General Hospital","city":"Manila","state":"Luzon","zip":"1000","country":"Philippines","geoPoint":{"lat":14.6042,"lon":120.9822}},{"facility":"The Medical City","city":"Pasig","state":"Luzon","zip":"1605","country":"Philippines","geoPoint":{"lat":14.58691,"lon":121.0614}},{"facility":"Veterans Memorial Medical Ctr","city":"Quezon City","state":"Luzon","zip":"1114","country":"Philippines","geoPoint":{"lat":14.6488,"lon":121.0509}},{"facility":"Perpetual Succour Hospital","city":"Cebu City","state":"Visayas","zip":"6000","country":"Philippines","geoPoint":{"lat":10.31672,"lon":123.89071}},{"facility":"Univ of Santo Tomas Hospital","city":"Manila","zip":"1008","country":"Philippines","geoPoint":{"lat":14.6042,"lon":120.9822}},{"facility":"St Luke's Medical Center","city":"Quezon City","zip":"1102","country":"Philippines","geoPoint":{"lat":14.6488,"lon":121.0509}},{"facility":"Centrul de Onc Medical Lasi","city":"Iași","zip":"700106","country":"Romania","geoPoint":{"lat":47.16667,"lon":27.6}},{"facility":"Spitalul Clinic Judetean Sibiu","city":"Sibiu","zip":"550245","country":"Romania","geoPoint":{"lat":45.8,"lon":24.15}},{"facility":"Spitalul Judetean de Urgente","city":"Suceava","zip":"720237","country":"Romania","geoPoint":{"lat":47.63333,"lon":26.25}},{"facility":"National Cancer Center","city":"Singapore","zip":"169610","country":"Singapore","geoPoint":{"lat":1.28967,"lon":103.85007}},{"facility":"Corporacio Sanitaria Parc","city":"Sabadell","state":"Barcelona","zip":"08208","country":"Spain","geoPoint":{"lat":41.54329,"lon":2.10942}},{"facility":"Hospital de Cruces","city":"Barakaldo","zip":"48903","country":"Spain","geoPoint":{"lat":43.29639,"lon":-2.98813}},{"facility":"Hospital del Mar","city":"Barcelona","zip":"08003","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital Clinic i Provincial","city":"Barcelona","zip":"08036","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital Universitario","city":"San Cristóbal de La Laguna","zip":"38320","country":"Spain","geoPoint":{"lat":28.4853,"lon":-16.32014}},{"facility":"Instituto Valenciano Oncologia","city":"Valencia","zip":"46009","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"Hospital Clinico Universitario","city":"Valencia","zip":"46010","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"Taichung Veterans Gen Hosp","city":"Dawan","zip":"407","country":"Taiwan","geoPoint":{"lat":23.20917,"lon":120.18722}},{"facility":"China Medical Univ Hosp","city":"Taichung","zip":"404","country":"Taiwan","geoPoint":{"lat":24.1469,"lon":120.6839}},{"facility":"National Taiwan University","city":"Taipei","zip":"112","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"Bumrungrad International Hosp","city":"Bangkok","zip":"10110","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"National Cancer Institute","city":"Bangkok","zip":"10400","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"Pramongkutklao Hospital","city":"Bangkok","zip":"10400","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"Siriraj Hospital","city":"Bangkok","zip":"10700","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"Maharaj Nakorn Chiang Mai Hosp","city":"Chiang Mai","zip":"50200","country":"Thailand","geoPoint":{"lat":18.79038,"lon":98.98468}},{"facility":"Bristol Heamatology & Onc Ctr","city":"Bristol","zip":"BS2 8ED","country":"United Kingdom","geoPoint":{"lat":51.45523,"lon":-2.59665}}]},"referencesModule":{"references":[{"pmid":"24101054","type":"DERIVED","citation":"Johnson BE, Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, Lin CY, Marsland T, Patel T, Polikoff J, Rubin M, White L, Yang JC, Bowden C, Miller V. ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer. J Clin Oncol. 2013 Nov 1;31(31):3926-34. doi: 10.1200/JCO.2012.47.3983. Epub 2013 Oct 7."}]}},"resultsSection":{"participantFlowModule":{"recruitmentDetails":"This study was conducted in 14 countries between 10 January 2006 and 19 June 2009.","groups":[{"id":"FG000","title":"Bevacizumab + Chemotherapy","description":"Participants received one of six chemotherapy regimens (Carboplatin + Paclitaxel or Carboplatin + Gemcitabine or Carboplatin + Docetaxel or Cisplatin + Gemcitabine or Cisplatin + Docetaxel / Cisplatin + vinorelbine) followed by Bevacizumab on Day 1 of each cycle up to 4 cycles."},{"id":"FG001","title":"Bevacizumab + Placebo","description":"Participants who completed four cycles of chemotherapy + bevacizumab received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib orally daily."},{"id":"FG002","title":"Bevacizumab + Erlotinib","description":"Participants who completed four cycles of chemotherapy + bevacizumab received received IV dose of Bevacizumab 15 mg/kg on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily."}],"periods":[{"title":"Chemotherapy Phase","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"1145"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"769"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"376"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"138"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Disease progression","reasons":[{"groupId":"FG000","numSubjects":"139"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Unwillingness or inability to comply","reasons":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Need for concomitant/ancillary therapy","reasons":[{"groupId":"FG000","numSubjects":"27"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Patient's decision to discontinue","reasons":[{"groupId":"FG000","numSubjects":"35"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Unrelated intercurrent illness","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"28"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]}]},{"title":"Post Chemotherapy Phase","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"373"},{"groupId":"FG002","numSubjects":"370"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"109"},{"groupId":"FG002","numSubjects":"126"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"264"},{"groupId":"FG002","numSubjects":"244"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"34"},{"groupId":"FG002","numSubjects":"38"}]},{"type":"Disease progression","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"204"},{"groupId":"FG002","numSubjects":"168"}]},{"type":"Unwillingness or inability to comply","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"5"}]},{"type":"Need for concomitant/ancillary therapy","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"5"}]},{"type":"Patient's decision to discontinue","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"8"}]},{"type":"Unrelated intercurrent illness","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"8"},{"groupId":"FG002","numSubjects":"11"}]},{"type":"Sponsor's decision to terminate study","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Not treated","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"7"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Bevacizumab + Placebo","description":"Participants received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib orally daily"},{"id":"BG001","title":"Bevacizumab + Erlotinib","description":"Participants received Bevacizumab 15 mg/kg IV on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"373"},{"groupId":"BG001","value":"370"},{"groupId":"BG002","value":"743"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"62.8","spread":"10.8"},{"groupId":"BG001","value":"62.9","spread":"10.3"},{"groupId":"BG002","value":"62.9","spread":"10.6"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"177"},{"groupId":"BG001","value":"177"},{"groupId":"BG002","value":"354"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"196"},{"groupId":"BG001","value":"193"},{"groupId":"BG002","value":"389"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Progression-free Survival (PFS)","description":"PFS was defined as the length of time from randomization until documented disease progression or death from any cause, whichever occurred earlier. Progression is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions. Data presented until cut-off date 18 July 2008.","populationDescription":"Intent to treat (ITT) population included all participants who were randomized during the post-chemotherapy phase.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"months","timeFrame":"Approximately 3 years","groups":[{"id":"OG000","title":"Bevacizumab + Placebo","description":"Participants who completed four cycles of chemotherapy + bevacizumab received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib orally daily."},{"id":"OG001","title":"Bevacizumab + Erlotinib","description":"Participants who completed four cycles of chemotherapy + bevacizumab received received IV dose of Bevacizumab 15 mg/kg on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"373"},{"groupId":"OG001","value":"370"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","lowerLimit":"2.86","upperLimit":"4.04"},{"groupId":"OG001","value":"4.8","lowerLimit":"4.14","upperLimit":"5.52"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0006","statisticalMethod":"Log Rank","paramType":"Hazard Ratio, log","paramValue":"0.708","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.580","ciUpperLimit":"0.864"}]},{"type":"SECONDARY","title":"Number of Participants With Prospectively Identified Treatment Emergent Adverse Events (TEAE) During Chemotherapy Phase","description":"Treatment-emergent adverse events were events between administration of study drug and up to 30 days after last dose of study drug that were absent before treatment or that worsened relative to pre-treatment state.. Number of participants who had Grade \\>=3TEAEs of pulmonary hemorrhage, gastrointestinal (GI) perforation, arterial thromboembolic (ATE) events, proteinuria, congestive heart failure (CHF), and hypertension were presented. Data presented up to data cutoff 18 July 2008.","populationDescription":"Safety-evaluable enrolled participants: All participants who enrolled and received at least one dose of chemotherapy or Bevacizumab. N= Number of participants analyzed.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"Approximately 3 years","groups":[{"id":"OG000","title":"Carboplatin + Paclitaxel","description":"Participants received Intravenous (IV) dose of Carboplatin at a dose based on an area under the concentration-time curve (AUC) of 6 milligram /milliliter (mg/mL) × minute (min) and Paclitaxel 200 milligram per square meter (mg/m\\^2) over 3 hours, respectively followed by Bevacizumab on Day 1 of each 21-day cycle up to 4 cycles."},{"id":"OG001","title":"Carboplatin + Gemcitabine","description":"Participants received IV dose of Carboplatin at a dose based on the AUC of 5 mg/mL × min on Day 1 of each 21-day cycle and Gemcitabine 1200 mg/m\\^2 on Day 1 and Day 8 followed by Bevacizumab of each 21-day cycle up to 4 cycles."},{"id":"OG002","title":"Carboplatin + Docetaxel","description":"Participants received IV dose of Carboplatin at a dose based on the AUC of of 6 mg/mL × min and Docetaxel 75 mg/m\\^2, respectively followed by Bevacizumab on Day 1 of each 21-day cycle up to 4 cycles."},{"id":"OG003","title":"Cisplatin + Gemcitabine","description":"Participants received IV dose of Cisplatin 80 mg/m\\^2 on Day 1 of each 21-day cycle and Gemcitabine 1000-1250 mg/m\\^2 on Day 1 and Day 8 followed by Bevacizumab of each 21-day cycle up to 4 cycles."},{"id":"OG004","title":"Other","description":"Included participants who received Cisplatin + Docetaxel or Cisplatin + vinorelbine, participants who received only one of the two chemotherapies planned followed by Bevacizumab of each 21-day cycle up to 4 cycles."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"524"},{"groupId":"OG001","value":"326"},{"groupId":"OG002","value":"162"},{"groupId":"OG003","value":"104"},{"groupId":"OG004","value":"28"}]}],"classes":[{"title":"Pulmonary hemorrhage","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"GI perforation","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"ATE events","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]},{"title":"Proteinuria","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"CHF","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Prospectively Identified Treatment Emergent Adverse Events (TEAE) During Post-Chemotherapy Phase","description":"Treatment-related adverse events are defined as new events that occur following subject entry into the study or events that worsen following study entry state and are judged by the investigator to be possibly, probably or definitely related to study medication. Pulmonary hemorrhage, GI perforation, ATE events, proteinuria, CHF, and hypertension were prospectively identified TEAEs of grade \\>=3. Data presented until cut-off date 28 January 2009.","populationDescription":"Safety-evaluable randomized Participants: All randomized Participants who received at least one complete or partial dose of Bevacizumab + Erlotinib or Bevacizumab + Placebo. N= Number of participants analyzed.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"Approximately 3 years","groups":[{"id":"OG000","title":"Bevacizumab + Placebo","description":"Participants who completed four cycles of chemotherapy + bevacizumab received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib orally daily."},{"id":"OG001","title":"Bevacizumab + Erlotinib","description":"Participants who completed four cycles of chemotherapy + bevacizumab received received IV dose of Bevacizumab 15 mg/kg on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"367"},{"groupId":"OG001","value":"368"}]}],"classes":[{"title":"Pulmonary hemorrhage","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"}]}]},{"title":"GI perforation","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"ATE events","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"8"}]}]},{"title":"Proteinuria","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"}]}]},{"title":"CHF","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"}]}]},{"title":"Hypertension","categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"23"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Any Adverse Events During Post-Chemotherapy Phase","description":"An AE is defined as any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An SAE is defined as any untoward medical occurrence that, at any dose, results in death, is life threatening, requires hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or is a significant medical event. Data presented up to data cutoff 19 June 2009.","populationDescription":"Safety-evaluable randomized Participants: All randomized Participants who received at least one complete or partial dose of Bevacizumab + Erlotinib or Bevacizumab + Placebo. N= Number of participants analyzed. At the time of the 28 January 2009 data cutoff, an additional 25 patients had been randomized.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"Approximately 3.5 years","groups":[{"id":"OG000","title":"Bevacizumab + Placebo","description":"Participants who completed four cycles of chemotherapy + bevacizumab received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib orally daily."},{"id":"OG001","title":"Bevacizumab + Erlotinib","description":"Participants who completed four cycles of chemotherapy + bevacizumab received received IV dose of Bevacizumab 15 mg/kg on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"367"},{"groupId":"OG001","value":"368"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"319"},{"groupId":"OG001","value":"353"}]}]}]},{"type":"SECONDARY","title":"Incidence of Study Treatment Discontinuation for Reasons Other Than Disease Progression in Chemotherapy Phase","description":"Participants who experienced disease progression were discontinued from the study. Data presented up to data cutoff (18 July 2008).","populationDescription":"Enrolled participants: All participants who were enrolled in the study. N= Number of participants analyzed.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"Approximately 3 years","groups":[{"id":"OG000","title":"Carboplatin + Paclitaxel","description":"Participants received Intravenous (IV) dose of Carboplatin at a dose based on an area under the concentration time curve (AUC) of 6 milligram /milliliter (mg/mL) × minute (min) and Paclitaxel 200 milligram per square meter (mg/m\\^2) over 3 hours, respectively followed by Bevacizumab on Day 1 of each 21-day cycle up to 4 cycles."},{"id":"OG001","title":"Carboplatin + Gemcitabine","description":"Participants received IV dose of Carboplatin at a dose based on the AUC of 5 mg/mL × min on Day 1 of each 21-day cycle and Gemcitabine 1200 mg/m\\^2 on Day 1 and Day 8 followed by Bevacizumab of each 21-day cycle up to 4 cycles."},{"id":"OG002","title":"Carboplatin + Docetaxel","description":"Participants received IV dose of Carboplatin at a dose based on the AUC of of 6 mg/mL × min and Docetaxel 75 mg/m\\^2, respectively followed by Bevacizumab on Day 1 of each 21-day cycle up to 4 cycles."},{"id":"OG003","title":"Cisplatin + Gemcitabine","description":"Participants received IV dose of Cisplatin 80 mg/m\\^2 on Day 1 of each 21-day cycle and Gemcitabine 1000-1250 mg/m\\^2 on Day 1 and Day 8 followed by Bevacizumab of each 21-day cycle up to 4 cycles."},{"id":"OG004","title":"Other","description":"Included participants who received Cisplatin + Docetaxel or Cisplatin + vinorelbine, participants who received only one of the two chemotherapies planned followed by Bevacizumab of each 21-day cycle up to 4 cycles."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"524"},{"groupId":"OG001","value":"326"},{"groupId":"OG002","value":"162"},{"groupId":"OG003","value":"104"},{"groupId":"OG004","value":"29"}]}],"classes":[{"title":"Adverse Event","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"14"},{"groupId":"OG004","value":"8"}]}]},{"title":"Concomitant/ancillary therapy","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"Patient's Decision to Discontinue","categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"0"}]}]},{"title":"Investigator's Decision","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"0"}]}]},{"title":"Unwillingness or inability to comply with study","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"Unrelated intercurrent illness","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"SECONDARY","title":"Incidence of Study Treatment Discontinuation","description":"Participants in post-chemotherapy phase were discontinued from the study for the reasons other than disease progression. Data presented Up to data cutoff 18 July 2008.","populationDescription":"Intent to treat (ITT) population included all participants who were randomized during the post-chemotherapy phase.. N= Number of participants analyzed.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"Approximately 3 years","groups":[{"id":"OG000","title":"Bevacizumab + Placebo","description":"Participants who completed four cycles of chemotherapy + bevacizumab received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib.\n\norally daily."},{"id":"OG001","title":"Bevacizumab + Erlotinib","description":"Participants who completed four cycles of chemotherapy + bevacizumab received received IV dose of Bevacizumab 15 mg/kg on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"373"},{"groupId":"OG001","value":"370"}]}],"classes":[{"title":"Bevacizumab: AE","categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"38"}]}]},{"title":"Bevacizumab: Concomitant/ancillary therapy","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"}]}]},{"title":"Bevacizumab: Patient's Decision to Discontinue","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"8"}]}]},{"title":"Bevacizumab: Investigator's Decision","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"11"}]}]},{"title":"Bevacizumab: Unwillingness or inability to comply","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"}]}]},{"title":"Bevacizumab: Unrelated intercurrent illness","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"Bevacizumab: Sponsor's decision","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Bevacizumab: Lost to follow-up","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"Erlotinib/placebo: AE","categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"48"}]}]},{"title":"Erlotinib/placebo: Concomitant/ancillary therapy","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"7"}]}]},{"title":"Erlotinib/placebo:Patient's Decision","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"10"}]}]},{"title":"Erlotinib/placebo: Investigator's Decision","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"12"}]}]},{"title":"Erlotinib/placebo:Unwillingness/inability comply","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"}]}]},{"title":"Erlotinib/placebo: Unrelated intercurrent illness","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"}]}]},{"title":"Erlotinib/placebo: Sponsor's decision","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Erlotinib/placebo: Lost to follow-up","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]}]},{"type":"SECONDARY","title":"Overall Survival","description":"Overall survival was defined as the length of time from randomization to death.","populationDescription":"Intent-to-treat population included all participants who were randomized during the post-chemotherapy phase.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"months","timeFrame":"Approximately 3.5 years","groups":[{"id":"OG000","title":"Bevacizumab + Placebo","description":"Participants who completed four cycles of chemotherapy + bevacizumab received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib orally daily."},{"id":"OG001","title":"Bevacizumab + Erlotinib","description":"Participants who completed four cycles of chemotherapy + bevacizumab received received IV dose of Bevacizumab 15 mg/kg on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"373"},{"groupId":"OG001","value":"370"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.3","lowerLimit":"12.12","upperLimit":"14.52"},{"groupId":"OG001","value":"14.4","lowerLimit":"12.29","upperLimit":"18.60"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.5341","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"0.917","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.698","ciUpperLimit":"1.205"}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Up to 30 days after discontinuation of study treatment","description":"Safety-evaluable randomized participants who had received at least one complete or partial dose of bevacizumab or erlotinib/placebo.","eventGroups":[{"id":"EG000","title":"Bevacizumab + Placebo","description":"Participants who completed four cycles of chemotherapy + bevacizumab received Bevacizumab 15 milligram per kilogram (mg/kg) intravenously (IV) on Day 1 of every 21-day cycle along with matched Placebo to Erlotinib orally daily.","seriousNumAffected":63,"seriousNumAtRisk":367,"otherNumAffected":288,"otherNumAtRisk":367},{"id":"EG001","title":"Bevacizumab + Erlotinib","description":"Participants who completed four cycles of chemotherapy + bevacizumab received received IV dose of Bevacizumab 15 mg/kg on Day 1 of every 21-day cycle along with Erlotinib as 150 mg per day orally daily.","seriousNumAffected":86,"seriousNumAtRisk":368,"otherNumAffected":341,"otherNumAtRisk":368}],"seriousEvents":[{"term":"Febrile neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Haemolytic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Atrial tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Sinus arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Adrenal insufficiency","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":4,"numAtRisk":368}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Food poisoning","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Gastrointestinal inflammation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Large intestine perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Oesophageal fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":3,"numAtRisk":368}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":5,"numAtRisk":368}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Hyperthermia","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Performance status decreased","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cholestasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Hepatitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Hyperbilirubinaemia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":367},{"groupId":"EG001","numAffected":4,"numAtRisk":368}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Lobar pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Catheter site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Encephalitic infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Escherichia infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Incision site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Staphylococcal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Device failure","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Mouth injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Muscle strain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Procedural complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Traumatic brain injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Wound complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Blood sodium decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Heart rate increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Weight decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":6,"numAtRisk":368}]},{"term":"Failure to thrive","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Hypovolaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Malignant pleural effusion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Metastases to meninges","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Metastases to spine","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Myelodysplastic syndrome","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Embolic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cerebellar infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cerebral artery embolism","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cerebral ischaemia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Cognitive disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Cranial neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Leukoencephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Neuropathy peripheral","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Reversible posterior leukoencephalopathy syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":5,"numAtRisk":368}]},{"term":"Hallucinations, mixed","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Renal failure acute","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":4,"numAtRisk":368}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":3,"numAtRisk":368}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":3,"numAtRisk":368}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Interstitial lung disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":2,"numAtRisk":368}]},{"term":"Pulmonary haemorrhage","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Bronchial haemorrhage","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Obstructive airways disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":367},{"groupId":"EG001","numAffected":3,"numAtRisk":368}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":367},{"groupId":"EG001","numAffected":0,"numAtRisk":368}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":367},{"groupId":"EG001","numAffected":1,"numAtRisk":368}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":367},{"groupId":"EG001","numAffected":19,"numAtRisk":368}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":367},{"groupId":"EG001","numAffected":19,"numAtRisk":368}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":33,"numAtRisk":367},{"groupId":"EG001","numAffected":34,"numAtRisk":368}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":72,"numAtRisk":367},{"groupId":"EG001","numAffected":188,"numAtRisk":368}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":39,"numAtRisk":367},{"groupId":"EG001","numAffected":75,"numAtRisk":368}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":367},{"groupId":"EG001","numAffected":27,"numAtRisk":368}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":367},{"groupId":"EG001","numAffected":38,"numAtRisk":368}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":367},{"groupId":"EG001","numAffected":20,"numAtRisk":368}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":367},{"groupId":"EG001","numAffected":18,"numAtRisk":368}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":91,"numAtRisk":367},{"groupId":"EG001","numAffected":126,"numAtRisk":368}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":367},{"groupId":"EG001","numAffected":26,"numAtRisk":368}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":367},{"groupId":"EG001","numAffected":20,"numAtRisk":368}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":367},{"groupId":"EG001","numAffected":23,"numAtRisk":368}]},{"term":"Weight decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":367},{"groupId":"EG001","numAffected":43,"numAtRisk":368}]},{"term":"Anorexia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":36,"numAtRisk":367},{"groupId":"EG001","numAffected":76,"numAtRisk":368}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":42,"numAtRisk":367},{"groupId":"EG001","numAffected":20,"numAtRisk":368}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":34,"numAtRisk":367},{"groupId":"EG001","numAffected":39,"numAtRisk":368}]},{"term":"Musculoskeletal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":35,"numAtRisk":367},{"groupId":"EG001","numAffected":28,"numAtRisk":368}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":367},{"groupId":"EG001","numAffected":29,"numAtRisk":368}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":367},{"groupId":"EG001","numAffected":23,"numAtRisk":368}]},{"term":"Dysgeusia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":367},{"groupId":"EG001","numAffected":23,"numAtRisk":368}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":45,"numAtRisk":367},{"groupId":"EG001","numAffected":38,"numAtRisk":368}]},{"term":"Neuropathy peripheral","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":367},{"groupId":"EG001","numAffected":28,"numAtRisk":368}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":367},{"groupId":"EG001","numAffected":32,"numAtRisk":368}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":367},{"groupId":"EG001","numAffected":23,"numAtRisk":368}]},{"term":"Proteinuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":367},{"groupId":"EG001","numAffected":24,"numAtRisk":368}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":66,"numAtRisk":367},{"groupId":"EG001","numAffected":63,"numAtRisk":368}]},{"term":"Dysphonia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":367},{"groupId":"EG001","numAffected":15,"numAtRisk":368}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":44,"numAtRisk":367},{"groupId":"EG001","numAffected":42,"numAtRisk":368}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":32,"numAtRisk":367},{"groupId":"EG001","numAffected":40,"numAtRisk":368}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":367},{"groupId":"EG001","numAffected":19,"numAtRisk":368}]},{"term":"Alopecia","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":367},{"groupId":"EG001","numAffected":26,"numAtRisk":368}]},{"term":"Dermatitis acneiform","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":367},{"groupId":"EG001","numAffected":58,"numAtRisk":368}]},{"term":"Dry skin","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":367},{"groupId":"EG001","numAffected":44,"numAtRisk":368}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":367},{"groupId":"EG001","numAffected":21,"numAtRisk":368}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":69,"numAtRisk":367},{"groupId":"EG001","numAffected":204,"numAtRisk":368}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (12.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":85,"numAtRisk":367},{"groupId":"EG001","numAffected":87,"numAtRisk":368}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."},"pointOfContact":{"title":"Roche Trial Information Hotline","organization":"F. Hoffmann-La Roche AG","email":"global.trial_information@roche.com","phone":"+41 616878333"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-12-17"},"conditionBrowseModule":{"meshes":[{"id":"D002289","term":"Carcinoma, Non-Small-Cell Lung"},{"id":"D008175","term":"Lung Neoplasms"}],"ancestors":[{"id":"D002283","term":"Carcinoma, Bronchogenic"},{"id":"D001984","term":"Bronchial Neoplasms"},{"id":"D012142","term":"Respiratory Tract Neoplasms"},{"id":"D013899","term":"Thoracic Neoplasms"},{"id":"D009371","term":"Neoplasms by Site"},{"id":"D009369","term":"Neoplasms"},{"id":"D008171","term":"Lung Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000068258","term":"Bevacizumab"},{"id":"D000069347","term":"Erlotinib Hydrochloride"}],"ancestors":[{"id":"D061067","term":"Antibodies, Monoclonal, Humanized"},{"id":"D000911","term":"Antibodies, Monoclonal"},{"id":"D000906","term":"Antibodies"},{"id":"D007136","term":"Immunoglobulins"},{"id":"D007162","term":"Immunoproteins"},{"id":"D001798","term":"Blood Proteins"},{"id":"D011506","term":"Proteins"},{"id":"D000602","term":"Amino Acids, Peptides, and Proteins"},{"id":"D012712","term":"Serum Globulins"},{"id":"D005916","term":"Globulins"},{"id":"D011799","term":"Quinazolines"},{"id":"D006574","term":"Heterocyclic Compounds, 2-Ring"},{"id":"D000072471","term":"Heterocyclic Compounds, Fused-Ring"},{"id":"D006571","term":"Heterocyclic Compounds"}]}},"hasResults":true}